MedTrace Logo

Focused Ultrasound (FUS) Mesencephalotomy for Head & Neck Cancer Pain

NCT03894553 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2025-10-23

No results posted yet for this study

Summary

This proposed pilot study will investigate the safety and initial effectiveness of focused ultrasound lesioning of the contralateral mesencephalon for severe, opioid-resistant pain associated with head and neck cancer

Conditions

  • Cancer of Head and Neck
  • Pain, Face
  • Pain, Neck

Interventions

DEVICE

ExAblate Neuro

Unilateral stereotactic focused ultrasound lesioning of the contralateral mesencephalon

Sponsors & Collaborators

  • Jeff Elias, MD

    lead OTHER

Principal Investigators

  • Jeff Elias · University of Virginia

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-22
Primary Completion
2025-08-31
Completion
2025-08-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03894553 on ClinicalTrials.gov